Centene Corp. and Washington University School of Medicine said Monday that they will partner to accelerate research into treatments for Alzheimer's disease, breast cancer, diabetes and obesity.
The Clayton-based managed health care provider will fund up to $100 million over 10 years in research at Washington U as part of the partnership, officials said. The funding will strengthen the medical school's Personalized Medicine Initiative, which targets development of customized disease treatment and…
